Newel Health

Newel Health is an innovative company that aims to improve healthcare for patients and doctors through the creation of beautifully designed and clinically validated digital medicine (DM) and digital therapeutic (DTx) solutions.
Born from an investment play by Healthware Ventures, the company has executed a series of strategic acquisitions of early-stage startups which now constitute a portion of its products’ pipeline.
Its team of experts, comprised of professionals in digital, data, behavioral, and scientific fields, have extensive experience in the life sciences industry.
Strategically partnering with pharmaceutical, medical device, and other health and wellness companies allows Newel Health to expand its customer reach and achieve its vision of future health. A long history of industry partnerships and a focus on patient-centricity enables successful outcomes in these shared initiatives.
Newel Health sprints out of the gate with two digital solutions: Amicomed, a Hypertension Control program that helps people lower their blood pressure via analytic insights of longitudinal blood pressure measurements and highly personalized behavioral lifestyle modification programs, and Soturi, a suite of digital services and smart algorithms that personalize and optimize the medication and treatment plans for people living with Parkinson’s disease.
The company actively researches and develops new digital product concepts in additional therapeutic areas with the goal of entering new partnerships and extending its portfolio of DTx solutions.
Newel Health also owns H.Core, a proprietary rapid-development SaMD (medical device software) framework designed to accelerate the design, validation, production, and launch of DM and DTx solutions.